Clinical Trial Update: Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating dopaminergic enhancement of rehabilitation therapy after stroke has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Unspecified dopaminergic agent used to augment rehabilitation

Snippet

Sponsor: University of California, Los Angeles | Conditions: Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-24